Tudor domains are widespread among proteins involved in RNA metabolism, but only in a few cases their cellular function has been analyzed in detail. Here, we report on the characterization of the ubiquitously expressed Tudor domain containing protein Tdrd3. Apart from its Tudor domain, we show that Tdrd3 possesses an oligosaccharide/nucleotide binding fold (OB-fold) and an ubiquitin associated domain capable of binding tetra-ubiquitin. A set of biochemical experiments revealed an interaction of Tdrd3 with FMRP, the product of the gene affected in Fragile X syndrome, and its autosomal homologs FXR1 and FXR2. FMRP has been implicated in the translational regulation of target mRNAs and shown to be a component of stress granules (SG). We demonstrate that overexpression of Tdrd3 in cells induces the formation of SGs and as a result leads to its co-localization with endogenous FMRP in these structures. Interestingly, the disease-associated FMRP missense mutation I304N identified in a Fragile X patient severely impairs the interaction with Tdrd3 in biochemical experiments. We propose a contribution of Tdrd3 to FMRPmediated translational repression and suggest that the loss of the FMRP -Tdrd3 interaction caused by the I304N mutation might contribute to the pathogenesis of Fragile X syndrome.
INTRODUCTION
Tudor domains are discernable sequence motifs of about 60 amino acids in numerous proteins and adopt a b barrel-like tertiary structure (1) . An emerging functional theme for proteins containing this domain is their involvement in various aspects of the metabolism of RNA (2) . This connection is easily inferred in the case of many Tudor domain containing (Tdrd) proteins, as these possess additional conserved sequence motifs predicted to bind RNA, for example in the case of Tdrd2 that bears a hnRNP K homology (KH) domain (3) or Tdrd10 that is predicted to contain an RNA recognition motif. Some members of this protein family contain domains in addition to the Tudor domain that do not directly point to an RNA related function, for example a myeloid-Nervy-DEAF-1 domain (MYND-domain; Tdrd1) (4) or a serine/threonine kinase domain (Tdrd8) (5) . Again others like SMNrp/SPF30, which has experimentally been proven to function in pre-mRNA splicing (6) , or the namegiving Drosophila Tudor-protein itself lack additional motifs. While the precise function of the latter protein and the identity of its interacting partners remain elusive, it has been shown to play a role in the organization of the pole plasm in oocytes and the nurse cell nuage (7) . The oocyte pole plasm gives rise to the germ cell lineage and is characterized by a large abundance of ribonucleoprotein particles (RNPs) (8) .
The Tudor domain containing protein studied thus far in most detail is the Survival Motor Neuron (SMN) protein. Reduced expression levels of this protein are the underlying cause for the neuronal disease spinal muscular atrophy (9) . SMN is part of a macromolecular complex (termed SMN complex), which mediates assembly of Sm proteins onto U snRNA (10) . During this essential step in the biogenesis of spliceosomal U snRNPs, the Tudor domain of SMN engages in important interactions, specifically in the binding of Sm proteins onto the SMN complex (1, 11) . Interestingly, this interaction appears to be stimulated by the modification of arginine residues within a subset of Sm proteins to symmetric di-methyl arginine (sDMA) (12, 13) . These observations along with structural studies have put forward the idea that Tudor domains are protein-protein interaction modules specifically designed to recognize sDMA-containing regions of proteins. In keeping with this notion, the Tudor domain of the splice factor SPF30/ SMNrp and of the thus far uncharacterized Tdrd3 protein have been suggested to bind sDMA-containing sequences (14) .
In the present study, we have performed experiments to gain insight into the cellular function of Tdrd3. This 83 kDa protein is unique in the Tdrd family, as it possesses an N-terminal oligosaccharide/nucleotide binding (OB) fold domain, a central ubiquitin binding associated (UBA) domain and a C-terminal Tudor domain. We find Tdrd3 to be expressed in a variety of tissues with a predominant cytosolic localization. The protein binds to tetraubiquitin by means of its UBA domain in vitro, suggesting a role for this protein in the proteolytic turnover of proteins mediated by the ubiquitinproteasome system. Interestingly, a series of biochemical and genetic protein interaction studies suggest that the Tdrd3 protein associates with the Fragile X mental retardation protein (FMRP), and its autosomal homologs FXR1 and FXR2. Limiting amounts of functional FMRP cause Fragile X syndrome, the most common form of inherited mental retardation worldwide (MIM no. 300624) (15) . Experimental evidence suggests that FMRP is engaged in post-transcriptional gene silencing events, in which mRNAs from actively translating polyribosomes are sequestered into translationally silent mRNPs. These mRNPs are generated as a consequence of various conditions of cellular stress, whereupon they accumulate in discrete cytoplasmic foci termed stress granules (SGs). Overexpression of Tdrd3 in HeLa cells results in the induction of such foci, where it co-localizes with endogenous FMRP. Strikingly, Tdrd3 interaction is abolished by the I304N missense mutation in FMRP associated with severe Fragile X syndrome. Taken together, our data reveal a novel FMRPassociated protein and suggest a role of Tdrd3 in FMRPmediated translational repression.
RESULTS

Tdrd3 is a conserved protein with a unique domain composition
We initially identified Tdrd3 in the ENSEMBL database by homology searches using the Tudor domain of SMN. Homology was restricted to the Tudor domain, but N-and C-terminal sequences were highly divergent to SMN.
BLAST searches revealed a high degree of conservation in a wide range of species including insects, the nematode C. elegans and deuterostomians such as the sea urchin and vertebrates. No Tdrd3-ortholog was detected in fungi and only a distantly related ortholog was present in plants. Together with the absence from S. cerevisiae and S. pombe, these findings point towards a function of Tdrd3 that developed later in eukaryotic evolution. To functionally analyze Tdrd3, PCR was performed from a human brain cDNA library using primers derived from the annotated EST sequences. Subsequent 5 0 -and 3 0 -RACE resulted in a cDNA of 2578 nucleotides encoding an open reading frame of 744 amino acids. This is in contrast to the Tdrd3 entry in ENSEMBL, where an open reading frame of only 651 amino acids is predicted (ENSP00 000196169). The difference most likely arises from different 5 0 and 3 0 splice sites for the first and second intron, respectively (data not shown), and results in the addition of 93 amino acids to the N-terminus of the protein. Importantly, this N-terminal sequence is annotated in Tdrd3 proteins from several other species such as rat, zebrafish or Drosophila (Fig. 1A , lower panel) and found in human EST databases (data not shown). The N-terminus of Tdrd3 shows homology to the OB-fold domain (16) , a single-stranded nucleic acid binding domain (17) . The structural hallmark of this motif is a b barrel consisting of five b sheets and an optional N-terminal a helix. Our full-length amino acid sequence is predicted to contain the complete five b-sheets typical of an OB-fold domain (Fig. 1A, lower panel) . Homology searches identified in addition a UBA domain located in between the N-terminal OB-fold and the Tudor domain. The domain organization of Tdrd3 is depicted in Figure 1A .
Tdrd3 is a ubiquitously expressed protein with cytosolic localization
In a series of experiments, we analyzed the expression pattern of Tdrd3 among tissues and its intracellular localization. Northern blot analysis of eight different tissues revealed a single band at 2.9 kb which was detected in all tissues studied (Fig. 1B) . The mRNA length corresponds to the size of the cloned cDNA with an additional poly(A) tail. Thus, Tdrd3 is expressed in a wide variety of tissues, which indicates a function common to a variety of cell types. To determine the sub-cellular localization of the protein in individual cells, a polyclonal antibody against human Tdrd3 was raised in rabbits, affinity purified and used for western blotting and indirect immunofluorescence experiments. In western blots of HeLa cytoplasmic extract and 293T total cell extract, a single band at 83 kDa was observed, matching the predicted molecular weight of Tdrd3 protein (Fig. 1C) . A corresponding signal was observed only in the cytosolic fraction of Xenopus laevis oocytes, but not in extracts derived from dissected nuclei (Fig. 1C) . Consistently, indirect immunofluorescence microscopy revealed a strong cytosolic localization with perinuclear accumulation in HeLa (Fig. 1D ) and COS-1 cells (data not shown). Similar results were obtained when HA -Tdrd3 transfected cells were analyzed (data not shown). Thus, Tdrd3 is a housekeeping gene with a predominant cytosolic localization.
The UBA domain of Tdrd3 specifically binds to Lys48-linked tetraubiquitin Next we set out to identify interactors of Tdrd3. We initially turned our attention to the UBA domain. Although originally discovered in proteins involved in ubiquitin-mediated proteolysis (18) , this domain has been shown more recently to be capable of acting as a general protein -protein interaction motif (19 -21) . Therefore, we immobilized GST fusions of full-length Tdrd3, Tdrd3 lacking the UBA domain or the isolated UBA domain on Glutathione -Sepahrose beads. The immobilized fusions were then incubated either with monoubiquitin, Lys 48 -linked tetraubiquitin (the signal for proteasomal degradation of proteins), Lys 63 -linked ubiquitin dimers (often found as non-proteolytic signals) or the small ubiquitinrelated modifier 1 (SUMO-1), which is structurally similar to ubiquitin yet divergent in its cellular function (22) . As shown in Figure 2A , the UBA domain of Tdrd3 is both necessary and sufficient for binding to Lys 48 linked tetraubiquitin. In contrast, no binding occurred to monoubiquitin, Lys 63 -linked ubiquitin or the small ubiquitin related modifier SUMO-1 (Fig. 2B) . As the major function of this type of modification is the targeting to proteasomes, these results suggest a role of Trdr3 in turnover of proteins mediated by the ubiquitinproteasome system.
FMRP and its paralogs interact with Tdrd3
In order to identify additional binding partners of Tdrd3, 2Â10 6 cDNA clones were tested in a yeast two hybrid (Y2H) interaction screen using Tdrd3 as bait. This approach revealed a strong interaction of Tdrd3 with the FXR1 protein. FXR1 is encoded by one of the two autosomal paralogs of the FMR1 gene, which is affected in patients suffering from Fragile X syndrome (23 (Fig. 3A) . Of note, the same results were obtained when experiments were conducted with immobilized GST -Tdrd3 and in vitro translated FMRP, FXR1 and FXR2 (data not shown). As binding of the investigated two proteins in these assays may be mediated by an unknown factor present in the reticulocyte lysate, direct interaction studies were performed with purified recombinant proteins. FMRP, FXR1 and FXR2 were expressed as ZZ-tagged fusion proteins, immobilized onto IgG-Sepharose and incubated with GSTTdrd3 protein. Tdrd3 bound to all ZZ-fusion proteins tested but not to the ZZ control (Fig. 3B) . Thus, Tdrd3 directly binds to FMRP and its homologs FXR 1 and 2 in vitro.
Next we analyzed whether the observed interaction between FMRP and Tdrd3 also occurs in the context of a living cell. To address this question, co-immunoprecipitation experiments of endogenous Tdrd3 and FMRP from cellular extracts were performed. As shown in Figure 3C , immunoprecipitation of FMRP leads to the co-precipitation of Tdrd3, and FMRP can be co-precipitated with Tdrd3 (Fig. 3C ). Taken together, by means of yeast two-hybrid assays, protein -protein interaction experiments and co-immunoprecipitation studies from cellular extracts, we establish Tdrd3 as a novel interactor of proteins of the FMRP/FXR family.
Tdrd3 is a novel component of stress granules
Previous studies have revealed a role of FMRP and its paralogs in posttranscriptional gene regulation. FXR1 has been shown to upregulate translation of certain mRNAs as a consequence of binding to AU-rich elements within the 3 0 -UTR of these RNAs (24) . In contrast, FMRP negatively regulates mRNA translation, most likely by interfering with ribosome subunit joining on mRNAs and thus formation of 80S ribosomes (25) . More recently, FMRP has also been connected to the micro-RNA pathway, but its precise role in this process remains elusive (26, 27) . Translational silencing is often linked to the emergence of SGs in cells. These are cytosolic foci that contain stalled 48S pre-initiation complexes, key components of microRNPs like Argonaute 2 (AGO2) and other RNA binding proteins (28, 29) . Indeed, FMRP-mediated translational regulation coincides with SG formation, a process that can also be induced by FMRP overexpression (Fig. 4A -C) (30) . Given that FMRP and Tdrd3 interact in vitro and in vivo, we asked whether overexpression of Tdrd3 can likewise induce SG formation. Indeed, upon overexpression, we observed a strong accumulation of both HA-tagged (Fig. 4D -F) and GFP-tagged Tdrd3 (Fig. 4G -I ) into discrete cytosolic foci. To confirm that these foci induced by Tdrd3 are indeed functional SGs, we investigated whether they are sensitive to cycloheximide or emetine. Both drugs are translational inhibitors that act by stalling ribosomes on mRNA, thus leading to the stabilization of polysomes and a decrease in 48S pre-initiation complexes. As the pool of translationally silent mRNPs in SGs is in equilibrium with the mRNAs in the polysomal fraction (31) , this results in reduced number and size of SGs (32) . Indeed, treatment of Tdrd3-transfected cells with either drug significantly reduced the amount of cytosolic granules in GFP-Tdrd3 positive cells (Fig. 4J -O) , suggesting that these granules are functional storage compartments of mRNPs. To ensure a direct link between emetine treatment and granule dispersion, time-lapse microscopy of individual cells was performed. Although under these experimental conditions, GFP -Tdrd3 containing foci were not dissociated completely, dissemination of distinct granules was clearly observed (Supplementary Material, Fig. S1 ), suggesting a direct influence of polysome stabilization on the turnover of these structures. Moreover, treatment of cells with arsenite, a potent inducer of cellular stress known to disrupt polysomes and induce SGs, led to the formation of Tdrd3-containing foci even in cells expressing only low levels of GFP-Tdrd3 (Figs 4P -R and Supplementary Material, Fig. S1 ). Next, we tested whether known SG markers co-localize to these foci. Therefore, immunofluorescence analysis was performed of GFP-Tdrd3-transfected cells with antibodies against the known SG proteins T-cell intracellular antigen-related protein (TIAR) (33), death associated protein 5 (DAP5) (34) and FMRP. Figure 5A -D shows TIAR-positive SGs induced by GFP-Tdrd3 overexpression. Notably, even upon SG induction by arsenite treatment (Fig. 5E -H) , when untransfected cells also showed TIAR-positive SGs (arrows), all SGs visible in transfected cells contained GFP -Tdrd3 (arrowheads). These results could be confirmed using DAP5 as SG marker ( Fig. 5I -P ). Finally, we tested the presence of FMRP in Tdrd3 containing SGs. Endogenous FMRP was efficiently recruited to GFP -Tdrd3 containing SGs in untreated and arsenite treated cells (Fig. 5Q -X) . These results were confirmed by analyzing endogenous FMRP and Tdrd3 in untransfected cells (Fig. 6) . While under non-stress conditions, both proteins were distributed throughout the cytosol (Fig. 6A -D) , arsenite treatment resulted in the induction of SGs containing both FMRP and Tdrd3 ( Fig. 6E and F) . Hence, these data confirm Tdrd3 as a novel SG component and suggest a functional link to FMRP-mediated translational regulation.
Mapping of the interaction between FMRP and Tdrd3
FMRP is a protein of 632 amino acids in length with three conserved RNA binding motifs. Two KH domains (KH1 and KH2) are found in the central part of the protein and an arginine -glycine rich domain in the C-terminal region. Having established an interaction between Tdrd3 and FMRP, we were next interested in narrowing down the sites in both proteins required for their mutual interaction. In a set of experiments, in vitro translated truncations of FMRP were incubated with immobilized full-length Tdrd3. Interestingly, two different fragments in the primary structure of FMRP are essential for Tdrd3 binding. First, a region spanning residues 430 -486 participate in the interaction. This is shown by the fact that binding of FMRP 1 -430 is not significantly higher than the background (Fig. 7B, compare lanes 4 and 15) , while FMRP 1 -486 shows strong binding (Fig. 7B, compare lanes 5  and 16) . Second, a region encompassing the two KH domains (amino acids 216 -332) is necessary for interaction with Tdrd3, as FMRP 216 -632 is efficiently bound (Fig. 7B,  lane 7) while FMRP 332 -632 fails to do so (Fig. 7B, lane 8) . Fragments lacking any one of these binding sites lose the ability to interact with Tdrd3, suggesting that both regions of the protein constituting the Tdrd3 binding site are brought into proximity of each other in the folded protein.
To map the corresponding FMRP-binding site in the Tdrd3 primary sequence, N-terminal and C-terminal truncated proteins were translated in vitro and tested for FMRP-binding activity. As shown in Figure 7D , the C-terminal region spanning amino acids 558-744 and encompassing the Tudor domain was sufficient for the interaction with Tdrd3 (Fig. 7D,  lane 4) . Surprisingly, the deletion of the Tudor domain failed to affect binding to FMRP (Fig. 7D, lane 5) . However, analysis of further truncations revealed that the 20 amino acids directly adjacent to the C-terminal boundary of the Tudor domain are necessary for binding to FMRP. Taken together, these results imply a model where a small stretch neighboring the Tudor domain of Tdrd3 interacts with a binding site in the middle of FMRP comprised of the KH domains and a region from residues 430-486 (Fig. 7E) .
A pathogenic amino acid substitution of FMRP prevents Tdrd3 binding
Although the majority of patients affected by Fragile-X syndrome exhibit an expansion of a CGG-repeat adjacent to the FMR gene leading to transcriptional silencing of FMRP, a missense mutation causing a single amino acid substitution (I304N) has been described in one patient (35) . Since the site of this missense mutation locates within FMRPs binding site for Tdrd3 (Fig. 7E) , we asked whether interaction between both proteins was affected. Therefore, ZZ-tagged wild-type or I304N mutant FMRP (FMRP I304N ) was immobilized onto IgG-Sepharose and binding of in vitro translated Tdrd3 was assessed (Fig. 8A) . Whereas wild-type FMRP bound Tdrd3 also stably under stringent conditions (750 mM NaCl, Fig. 8A, lane 4) , only low levels of Tdrd3 binding to FMRP I304N were detected even at physiological salt concentrations (Fig. 8A, lane 5) . This indicates that the I304N mutation abolishes the binding capacity of the Tdrd3 protein to FMRP.
Previous studies had shown that wild-type FMRP forms homo-oligomers in vitro, and that homo-oligomerization of FMRP I304N is severely compromised. Hetero-oligomerization between wild-type and mutant FMRP, in contrast, was not affected (25) . Hence, we tested whether formation of FMRP oligomers is a pre-requisite for Tdrd3 binding (Fig. 8B ). For this, ZZ-tagged FMRP wt (Fig. 8B, lanes 1 and 2) and FMRP I304N (lanes 3 and 4) were immobilized onto IgGSepharose. Oligomerization was initiated by the addition of Histagged FMRP wt (lanes 1 and 3) or FMRP I304N (lanes 2 and 4) down radiolabeled Tdrd3 (Fig. 8B, lane 4, lower panel) . Therefore, although the loss of Tdrd3 binding seems to correlate with reduced homooligomerization, we propose that binding deficiency is a direct effect of the I304N mutation on FMRP/Tdrd3 interaction rather than a consequence of impaired oligomerization. Surprisingly, FMRP wt /FMRP I304N hetero-oligomers bound Tdrd3 as efficient as wild-type homooligomers (Fig. 8B, lower panel, lanes 1 -3) . As a consequence, hetero-oligomer formation by FMRP I304N expression in an FMRP wt background should be sufficient to induce SGs in cells. This was tested by the transfection of HeLa cells with HA-tagged FMRP I304N , which indeed resulted in the formation of SGs comparable to wild-type FMRP transfection (Fig. 8C-J) . Also, no significant deficiency in the recruitment of endogenous Tdrd3 (Fig. 8B and F) or co-transfected GFP -Tdrd3 (Supplementary Material, Fig. S2 ) to FMRP I304N -induced SGs could be observed, suggesting that FMRP wt / FMRP I304N hetero-oligomers are functional in vivo.
DISCUSSION
Tdrd3 contains motifs implicated in a variety of different cellular processes
In this study, we aimed at providing a first biochemical and functional characterization of the Tudor domain containing protein Tdrd3. While the structure of murine Tdrd3's Tudor domain has recently been solved (PDB ID: 2D9T) and has been suggested to be a binding platform for proteins containing symmetrical dimethylarginine (14) , functional implications for Tdrd3 remained elusive. Homology-based sequence alignment suggests that the N-terminal part of Tdrd3 constitutes an OB-fold domain. This domain is frequently found in proteins with affinity to single-stranded DNA and/or RNA. Interestingly, while only four of the five b-sheets characteristic for an OB-fold domain could be identified in the current database entries of Tdrd3, our 5 0 -RACE identified an additional sequence with an in-frame upstream initiator methionine codon. The open reading frame encoded by this additional sequence is predicted by PSI-PRED to contain a kinked b-strand typical for the OB-fold b1 strand (17) . In the middle part of the protein, a UBA domain is located whose structure has recently been solved by NMR spectroscopy (PDB ID: 1WJI). Complementary to this structural information, we provide evidence that the UBA domain binds to Lys 48 -linked tetraubiquitin, i.e. the signal for the proteosomal degradation of proteins (Fig. 2) . Remarkably, this interaction is highly specific as neither monoubiquitin, Lys 63 -linked ubiquitin dimers, nor the ubiquitin-related protein SUMO bound to detectable levels to Tdrd3's UBA domain in vitro. It is, therefore, a possibility that Tdrd3 associates with proteins designated for proteasomal degradation (36) .
Direct interaction of Tdrd3 with FMRP
By Northern blot analysis, we find the Tdrd3-mRNA to be expressed in a large spectrum of tissues, indicating a function in basal cellular processes rather than in tissue-specific pathways. In cultured cells and in Xenopus oocytes, the Tdrd3 protein was found to be predominantly cytosolic. Indirect immunofluorescence in cultured cells also revealed an occasional faint nuclear staining. Whether this points to an additional function of Tdrd3 in the nucleus is currently unclear. Hence, Tdrd3 is likely to perform its function in the cytoplasm of cells.
To identify proteins interacting with the Tdrd3 protein, we performed an Y2H screen using a human brain cDNA library. Interestingly, FXR1, the autosomal paralog of the Fragile X mental retardation protein FMRP, emerged as a robust interacting protein out of this screen. Although not identified in the two hybrid screen, we also found strong binding of Tdrd3 with FXR2, the second protein closely related to FMRP, and with FMRP itself. The association with the latter is of particular interest, as this protein is known to be absent or mutated in the Fragile X-mental retardation syndrome. This interaction has been confirmed by two independent and complementary techniques. First, direct contact of FMRP with Tdrd3 was observed when recombinantly expressed proteins were analyzed by in vitro binding assays. Second, and most importantly, we also detected binding of FMRP and Tdrd3 to each other by co-immunoprecipitation from cellular extracts, making it likely that one direct interaction partner of Tdrd3 in vivo is FMRP.
Interaction mapping has revealed binding of FMRP to a stretch of 20 amino acids adjacent to the C-terminal boundary of the Tudor domain of Tdrd3 (amino acids 704 -723). FMRP in turn contacts Tdrd3 via two sequence elements, the second KH domain and a stretch comprising amino acids 430 -486.
As both elements are necessary but individually not competent in binding, we hypothesize that these two regions come into close proximity in the tertiary structure of the protein to form the binding platform for Tdrd3.
Most Fragile X patients exhibit mutations in the FMR1 gene that lead to transcriptional silencing and hence to the absence of FMRP. In a single case, however, also the substitution of an isoleucine to an asparagine in position 304 (I304N) elicits the disease. This mutation has been shown to interfere with several functions of FMRP, including mRNA binding, homodimerization and translational regulation. Remarkably, when tested in in vitro binding assays, FMRP I304N failed to interact with Tdrd3. These data are consistent with our finding that a region surrounding this residue is important for Tdrd3 binding.
It has recently been proposed that SMN interacts with FMRP and that this interaction is dependent on the amino acids 470-485 of FMRP (37) . It will be interesting to analyze whether SMN and Tdrd3 compete for FMRP binding. However, SMN interaction is unaffected by the FMRP I304N mutation (37) and hence the binding sites appear to differ at least partially.
Tdrd3 as a component of stress granules
It is known from previous work that FMRP inhibits translation of mRNAs, most likely at the level of translation initiation (25) . Current research focuses on the role of FMRP after stress stimuli such as heat and osmotic shock or oxidative stress. Under these conditions, FMRP concentrates in SGs, where translational silencing of mRNAs occurs (30) . It is known that overexpression of FMRP and other components involved in mRNA metabolism likewise induces formation of SGs. Several lines of evidence suggest that the cytosolic foci induced by overexpression of Tdrd3 are equivalent to these structures. First, they disperse upon treatment of cells with either cycloheximide or emetine, showing them to be in equilibrium with polyribosomes bound to translated mRNAs. Second, arsenite treatment induces Tdrd3 containing granules even in cells expressing only low levels of Tdrd3. Tdrd3 in these cells has no aggregates in the absence of this stress-inducing agent. Last, Tdrd3 co-localizes with three known SG marker proteins, namely TIAR, DAP5 and FMRP, in these foci. Based on these results, we conclude that Tdrd3 is a novel component in SGs where it interacts with FMRP.
Our data raise the possibility that Tdrd3 functions in FMRP-mediated translational silencing. Consistent with this is our preliminary observation that Tdrd3 itself represses translation in an in vitro system (data not shown). Since Tdrd3 binds to Lys 48 -linked tetraubiquitin, it is tempting to speculate that Tdrd3 provides a link between translational regulation in SGs and the turnover of proteins mediated by the ubiquitin-proteasome system. Alternatively and not mutually exclusive, Tdrd3 may aid the removal of proteins co-recruited with the silenced RNP by proteasomal degradation. It is worth to mention that HDAC6, another protein containing an ubiquitin binding motif has recently been shown to be necessary for SG formation (38) and that interfering with the ubiquitin-proteasome system can induce SGs (39) . Clearly, it will be interesting to identify proteins whose stability and/or function is influenced by Tdrd3.
MATERIALS AND METHODS
Cloning of Tdrd3-cDNA
Tdrd3-cDNA was amplified using the 'Marathon human brain cDNA' library (Clontech) with transcript-specific primers. 5 0 -and 3 0 -RACE-PCR was carried out using the 'Marathon RACE Kit' (Clontech) according to the manufacturer's instructions. Tdrd3-cDNA and fragments thereof, respectively, were subcloned into pET21a-ZZ for expression with a ZZ tag and pHA, an N-terminal HA tag containing derivative of pcDNA3.1 (Invitrogen). FMRP, FXR1 and FXR2 constructs were generated as described (25) .
Preparation of recombinant proteins and antibodies
Recombinant FMRP, FXR1 and FXR2 proteins were expressed and purified as described previously (25) . pET21a -ZZ-Tdrd3 and pGEX5X1 -Tdrd3 were transformed in E. coli BL21(DE3) and after induction with 1 mM IPTG expression was allowed for 5 h at 268C. Pelleted bacteria were resuspended in 500 mM NaCl, 50 mM Tris -HCl (pH 7.4), 5 mM MgCl 2 , 0.02% (v/v) Igepal CA630 (P500) supplemented with 0.5 mM PMSF. Suspensions were lysed by sonication and cleared by centrifugation. GST-or His-tagged fusion protein containing supernatants were incubated with Glutathione -Sepharose (GE Life Sciences) or Ni-NTA (Qiagen), respectively, washed with the same buffer except for 300 mM NaCl (P300) and bound proteins were eluted with 10 mM glutathione in P300 for GST-fusion proteins or 150 mM imidazole in P300 for His-tagged proteins. After elution, proteins were dialysed against P300. In vitro translated proteins were generated by coupled transcription and translation in reticulocyte lysate (Promega, Madison, WI, USA). Rabbits were immunized with His-tagged Tdrd3 protein as described (6) and the serum affinity purified using His-Tdrd3 covalently bound to NHS-activated Sepharose (GE Life Sciences). Commercial primary antibodies were purchased from Santa Cruz (goat polyclonal anti-DAP5: sc-13736), Covance (mouse monoclonal anti-HA antibody: HA.11) and abcam (rabbit polyclonal anti-TIAR; ab26257).
Protein binding assays
For protein binding assays, lysates containing 1-2 mg of ZZ-tagged fusion proteins were incubated on 30 ml of IgG-Sepharose (GE Life Sciences). For GST-fusion proteins, 1-2 mg of the purified protein were incubated with 30 ml Glutathione -Sepharose. After washing, with P300, 1-5 ml of an in vitro translation reaction or 1 -2 mg of purified recombinant protein were added and binding was allowed for 2 h at 48C. After washing, the affinity matrix was transferred to a new tube and bound proteins were recovered with SDS-loading buffer and analyzed by SDS -PAGE. For ubiquitin binding assays, GST-fusion proteins were immobilized on Glutathione -Sepharose and incubated with monomeric ubiquitin, Lys 48 -and Lys 63 -linked tetraubiquitin, respectively. After washing with PBS containing 0.5% Tween 20, proteins were eluted with SDS-loading buffer and immunoblot was performed using anti-ubiquitin antibody.
Yeast two-hybrid screen
Tdrd3 was cloned into the pGBKT7 vector and transformed in the PJ69-2A bait strain. After selection on SDC medium without tryptophane, mating with the Y187 prey strain that was pre-transformed with a human brain cDNA-bank in the pACT2 vector (Matchmaker, Clontech) was performed. Colonies growing on SDC-Medium without leucine, tryptophane, adenine and histidine were assayed for b-galactosidase activity and positive clones recovered for plasmid preparation. 
Immunocytochemistry and stress treatment
HeLa cells were grown on cover slips in DMEM medium containing 10% fetal calf serum at 378C and 5% CO 2 . One day after transfection with Nanofectin (PAA), cells were fixed either with 2% formaldehyde, permeabilized with 0.2% Triton X 100 and blocked with 1% bovine serum albumin (BSA) or in case of drug treatment fixed with ice-cold methanol/acetone (1:1) and blocked with 1% BSA. Treatment with cycloheximide (50 mg/ml), emetine (20 mg/ml) or arsenite (500 mM) was performed for 1 h immediately before fixation. After incubation with primary antibody, cells were washed and incubated with an appropriate secondary antibody conjugated to AlexaFluor594 or AlexaFluor488 (Invitrogen). After washing, cells were embedded in DAPI containing mounting medium and analyzed with a Zeiss Axiovert 200M equipped with a Plan Apochromat 63x/1.40 Oil immersion objective and Nomarski optics. Images were acquired with AxioVision software and processed using Adobe Photoshop CS3.
Northern blotting
A Northern blot membrane with 2 mg polyAþmRNA from eight different human tissues was purchased from Clontech. Tdrd3 cDNA was radioactively labeled using Klenow fragment with the 'Megaprime DNA labeling kit' (GE Life Sciences) according to the manufacturer's description. The membrane was blocked with 900 mM NaCl, 50 mM NaH2PO4, 5 mM EDTA, 50% (v/v) formamide, 0.1% (w/v) SDS, 0.04% (w/v) Ficoll 400, 0.04% (w/v) polyvinylpyrrolidone, 0.04% (w/v) BSA, 100 mg/ml herring sperm DNA followed by hybridization for 3 h at 428C. Washing was carried out once with 2x SSCþ buffer at 428C, and consecutively with decreasing concentration and increasing temperature until 0.1x SSC at 608C 
